galactosamine has been researched along with amygdalin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bian, C; Fan, K; Tang, F; Wang, K | 1 |
1 other study(ies) available for galactosamine and amygdalin
Article | Year |
---|---|
Amygdalin attenuates acute liver injury induced by D-galactosamine and lipopolysaccharide by regulating the NLRP3, NF-κB and Nrf2/NQO1 signalling pathways.
Topics: Amygdalin; Animals; Antineoplastic Agents, Phytogenic; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Female; Galactosamine; Hep G2 Cells; Humans; Lipopolysaccharides; Mice; Mice, Inbred BALB C; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction | 2019 |